Clinical Trial: Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China

U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07375355) titled 'Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China' on Jan. 21.

Brief Summary: This is a multicenter, non-interventional real-world study designed to assess the efficacy and safety of asciminib in patients with newly diagnosed CML.The study uses a prospective data collection design to gather baseline, pre- and post-treatment, and long-term follow-up data, enabling a comprehensive assessment of asciminib's clinical benefits.

Study Start Date: Feb. 27

Study Type: OBSERVATIONAL

Condition: Chronic Myeloid Leukemia in Chronic Phase

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Novartis Pharmaceutic...